Skip to main content
Erschienen in: Journal of Neurology 4/2016

17.10.2015 | Review

“Orbiting around” the orbital myositis: clinical features, differential diagnosis and therapy

verfasst von: F. Montagnese, S. Wenninger, B. Schoser

Erschienen in: Journal of Neurology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Orbital myositis (OM) is a rare disease whose clinical heterogeneity and different treatment options represent a diagnostic and therapeutic challenge. We aim to review the state of knowledge on OM, also describing a cohort of patients diagnosed in our centre, to highlight some remarkable clinical features. A literature review was conducted in PubMed and Medline databases. The herein described cohort is composed of seven OM patients, diagnosed according to clinical, laboratory and neuroradiological features, whose clinical data were retrospectively analysed. OM is a non-infectious, inflammatory process primarily involving extraocular eye-muscles. It typically presents as an acute to sub-acute, painful ophthalmoplegia with signs of ocular inflammation, but atypical cases without pain or with a chronic progression have been described. The wide range of OM mimicking diseases make a prompt diagnosis challenging but orbit MRI provides valuable clues for differential diagnosis. Timely treatment is greatly important as OM promptly responds to steroids; nevertheless, partial recovery or relapses often occur. In refractory, recurrent or steroid-intolerant cases other therapeutic options (radiotherapy, immunosuppressants, immunoglobulins) can be adopted, but the most effective therapeutic management is yet to be established. In this review, we provide a detailed clinical description of OM, considering the main differential diagnoses and suggesting the most useful investigations. In light of the currently available data on therapy efficacy, we propose a therapeutic algorithm that may guide neurologists in OM patients’ management.
Literatur
1.
Zurück zum Zitat Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 121:491–499CrossRefPubMed Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 121:491–499CrossRefPubMed
2.
Zurück zum Zitat Harris GJ (2006) Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg 22:79–86CrossRefPubMed Harris GJ (2006) Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg 22:79–86CrossRefPubMed
3.
Zurück zum Zitat Dalakas MC (2006) Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 16(4):223–236CrossRefPubMed Dalakas MC (2006) Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 16(4):223–236CrossRefPubMed
4.
Zurück zum Zitat Jacob M, Ollagnon Roman E, Vighetto A (2007) Familial orbital myositis. J Neurol 254:666–667CrossRefPubMed Jacob M, Ollagnon Roman E, Vighetto A (2007) Familial orbital myositis. J Neurol 254:666–667CrossRefPubMed
5.
Zurück zum Zitat Siatkowski RM, Capó H, Byrne SF et al (1994) Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol 118:343–350CrossRefPubMed Siatkowski RM, Capó H, Byrne SF et al (1994) Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol 118:343–350CrossRefPubMed
6.
Zurück zum Zitat Mombaerts I, Koornneef L (1997) Current status in the treatment of orbital myositis. Ophthalmology 104:402–408CrossRefPubMed Mombaerts I, Koornneef L (1997) Current status in the treatment of orbital myositis. Ophthalmology 104:402–408CrossRefPubMed
8.
Zurück zum Zitat Ota M, Shimizu T, Yoshida H et al (2014) Clinical features and therapeutic responses of idiopathic orbital myositis. Neurol Clin Neurosci 3:63–67CrossRef Ota M, Shimizu T, Yoshida H et al (2014) Clinical features and therapeutic responses of idiopathic orbital myositis. Neurol Clin Neurosci 3:63–67CrossRef
9.
Zurück zum Zitat Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ (2012) Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol 96:276–280CrossRefPubMed Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ (2012) Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol 96:276–280CrossRefPubMed
10.
Zurück zum Zitat Spindle J, Narang S, Purewal B, Shinder R (2013) Atypical idiopathic orbital inflammation in a young girl. Ophthal Plast Reconstr Surg 29:86–88CrossRef Spindle J, Narang S, Purewal B, Shinder R (2013) Atypical idiopathic orbital inflammation in a young girl. Ophthal Plast Reconstr Surg 29:86–88CrossRef
11.
Zurück zum Zitat Gori S, Lucchesi C, Calabrese R et al (2013) Inferior rectus myositis: a rare cause of painful ophthalmoplegia and a therapeutic challenge. Neurol Sci 34:789–791CrossRefPubMed Gori S, Lucchesi C, Calabrese R et al (2013) Inferior rectus myositis: a rare cause of painful ophthalmoplegia and a therapeutic challenge. Neurol Sci 34:789–791CrossRefPubMed
12.
Zurück zum Zitat Sahlin S, Lignell B, Williams M, Dastmalchi M, Orrego A (2009) Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol 87:906–908CrossRefPubMed Sahlin S, Lignell B, Williams M, Dastmalchi M, Orrego A (2009) Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol 87:906–908CrossRefPubMed
13.
Zurück zum Zitat Garcia-Pous M, Hernández-Garfella ML, Díaz-Llopis M (2007) Treatment of chronic orbital myositis with daclizumab. Can J Ophthalmol 42:156–157CrossRefPubMed Garcia-Pous M, Hernández-Garfella ML, Díaz-Llopis M (2007) Treatment of chronic orbital myositis with daclizumab. Can J Ophthalmol 42:156–157CrossRefPubMed
14.
Zurück zum Zitat Hernández-Garfella ML, Gracia-García A, Cervera-Taulet E, García-Villanueva C, Montero-Hernández J (2011) Adalimumab for recurrent orbital myositis in Crohn’s disease: report of a case with a 3-year follow-up. J Crohns Colitis 5:265–266CrossRefPubMed Hernández-Garfella ML, Gracia-García A, Cervera-Taulet E, García-Villanueva C, Montero-Hernández J (2011) Adalimumab for recurrent orbital myositis in Crohn’s disease: report of a case with a 3-year follow-up. J Crohns Colitis 5:265–266CrossRefPubMed
15.
Zurück zum Zitat Mannor GE, Rose GE, Moseley IF, Wright JE (1997) Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology 104:409–414CrossRefPubMed Mannor GE, Rose GE, Moseley IF, Wright JE (1997) Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology 104:409–414CrossRefPubMed
17.
Zurück zum Zitat Fraser CL, Skalicky SE, Gurbaxani A, McCluskey P (2013) Ocular myositis. Curr Allergy Asthma Rep 13:315–321CrossRefPubMed Fraser CL, Skalicky SE, Gurbaxani A, McCluskey P (2013) Ocular myositis. Curr Allergy Asthma Rep 13:315–321CrossRefPubMed
18.
Zurück zum Zitat Schoser B (2007) Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease—five new cases and review. Clin Ophthalmol 1:37–42PubMedPubMedCentral Schoser B (2007) Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease—five new cases and review. Clin Ophthalmol 1:37–42PubMedPubMedCentral
19.
Zurück zum Zitat Peter J, Andrew NH, Smith C, Figueira E, Selva D (2014) Idiopathic inflammatory orbital myositis presenting with vision loss. Orbit 33:449–452CrossRefPubMed Peter J, Andrew NH, Smith C, Figueira E, Selva D (2014) Idiopathic inflammatory orbital myositis presenting with vision loss. Orbit 33:449–452CrossRefPubMed
20.
Zurück zum Zitat Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BG (2009) Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry 80:1293–1295CrossRefPubMed Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BG (2009) Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry 80:1293–1295CrossRefPubMed
21.
Zurück zum Zitat Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ (2012) Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol 27:759–766CrossRefPubMedPubMedCentral Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ (2012) Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol 27:759–766CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458CrossRefPubMed Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458CrossRefPubMed
23.
Zurück zum Zitat McNab AA, McKelvie P (2015) IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg 31:167–178CrossRefPubMed McNab AA, McKelvie P (2015) IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg 31:167–178CrossRefPubMed
24.
Zurück zum Zitat Chaudhry IA, Elkhamry SM, Al-Rashed W, Bosley TM (2009) Carotid cavernous fistula: ophthalmological implications. Middle East Afr J Ophthalmol 16:57–63CrossRefPubMedPubMedCentral Chaudhry IA, Elkhamry SM, Al-Rashed W, Bosley TM (2009) Carotid cavernous fistula: ophthalmological implications. Middle East Afr J Ophthalmol 16:57–63CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Preechawat P, Narmkerd P, Jiarakongmun P, Poonyathalang A, Pongpech SM (2008) Dural carotid cavernous sinus fistula: ocular characteristics, endovascular management and clinical outcome. J Med Assoc Thai 91:852–858PubMed Preechawat P, Narmkerd P, Jiarakongmun P, Poonyathalang A, Pongpech SM (2008) Dural carotid cavernous sinus fistula: ocular characteristics, endovascular management and clinical outcome. J Med Assoc Thai 91:852–858PubMed
26.
Zurück zum Zitat Rodrigues T, Willinsky R, Agid R, TerBrugge K, Krings T (2014) Management of dural carotid cavernous fistulas: a single-centre experience. Eur Radiol 24:3051–3058CrossRefPubMed Rodrigues T, Willinsky R, Agid R, TerBrugge K, Krings T (2014) Management of dural carotid cavernous fistulas: a single-centre experience. Eur Radiol 24:3051–3058CrossRefPubMed
27.
28.
Zurück zum Zitat Sauer A, Speeg-Schatz C, Hansmann Y (2011) Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis 2011:372470PubMedPubMedCentral Sauer A, Speeg-Schatz C, Hansmann Y (2011) Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis 2011:372470PubMedPubMedCentral
29.
Zurück zum Zitat Patheja RS, Weaver T, Morris S (2015) Unique case of orbital myositis and dacryoadenitis preceding the vesicular rash of Herpes zoster ophthalmicus. Clin Exp Ophthalmol. doi:10.1111/ceo.12584 Patheja RS, Weaver T, Morris S (2015) Unique case of orbital myositis and dacryoadenitis preceding the vesicular rash of Herpes zoster ophthalmicus. Clin Exp Ophthalmol. doi:10.​1111/​ceo.​12584
30.
Zurück zum Zitat Mavrikakis I, Rootman J (2007) Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 144:769–775CrossRefPubMed Mavrikakis I, Rootman J (2007) Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 144:769–775CrossRefPubMed
31.
Zurück zum Zitat Salam A, Meligonis G, Malhotra R (2008) Superior oblique myositis as an early feature of orbital Wegener’s granulomatosis. Orbit 27:203–206CrossRefPubMed Salam A, Meligonis G, Malhotra R (2008) Superior oblique myositis as an early feature of orbital Wegener’s granulomatosis. Orbit 27:203–206CrossRefPubMed
32.
Zurück zum Zitat Arrico L, Abbouda A, Bianchi S, Malagola R (2014) Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep 8:375CrossRefPubMedPubMedCentral Arrico L, Abbouda A, Bianchi S, Malagola R (2014) Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep 8:375CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Verma S, Kroeker KI, Fedorak RN (2013) Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol 13:59CrossRefPubMedPubMedCentral Verma S, Kroeker KI, Fedorak RN (2013) Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol 13:59CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Sogabe Y, Ohshima K, Azumi A et al (2014) Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252:531–538CrossRefPubMed Sogabe Y, Ohshima K, Azumi A et al (2014) Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252:531–538CrossRefPubMed
35.
Zurück zum Zitat Deschamps R, Deschamps L, Depaz R et al (2013) High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series. Br J Ophthalmol 97:999–1004CrossRefPubMed Deschamps R, Deschamps L, Depaz R et al (2013) High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series. Br J Ophthalmol 97:999–1004CrossRefPubMed
36.
Zurück zum Zitat Pakdaman MN, Sepahdari AR (2014) Elkhamary SM Orbital inflammatory disease: pictorial review and differential diagnosis. World J Radiol 6:106–115CrossRefPubMedPubMedCentral Pakdaman MN, Sepahdari AR (2014) Elkhamary SM Orbital inflammatory disease: pictorial review and differential diagnosis. World J Radiol 6:106–115CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Khosroshahi A, Carruthers MN, Deshpande V et al (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Med (Baltim) 91:57–66CrossRef Khosroshahi A, Carruthers MN, Deshpande V et al (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Med (Baltim) 91:57–66CrossRef
38.
Zurück zum Zitat Gordon LK (2006) Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond) 20(10):1196–1206CrossRef Gordon LK (2006) Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond) 20(10):1196–1206CrossRef
39.
Zurück zum Zitat Lazarus JH (2012) Epidemiology of Graves’ orbitopathy, (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26:273–279CrossRefPubMed Lazarus JH (2012) Epidemiology of Graves’ orbitopathy, (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26:273–279CrossRefPubMed
40.
Zurück zum Zitat Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in graves’ ophthalmopathy. Ophthalmology 118:2279–2285CrossRefPubMed Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in graves’ ophthalmopathy. Ophthalmology 118:2279–2285CrossRefPubMed
41.
Zurück zum Zitat Zöphel K, Roggenbuck D, Schott M (2010) Clinical review about TRAb assay’s history. Autoimmun Rev 9:695–700CrossRefPubMed Zöphel K, Roggenbuck D, Schott M (2010) Clinical review about TRAb assay’s history. Autoimmun Rev 9:695–700CrossRefPubMed
42.
Zurück zum Zitat Kan E, Kan EK, Ecemis G, Colak R (2014) Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis. Int J Ophthalmol 7:644–647PubMedPubMedCentral Kan E, Kan EK, Ecemis G, Colak R (2014) Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis. Int J Ophthalmol 7:644–647PubMedPubMedCentral
43.
44.
Zurück zum Zitat Perros P, Žarković M, Azzolini C et al (2015) PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. doi:10.1136/bjophthalmol-2015-306733 PubMed Perros P, Žarković M, Azzolini C et al (2015) PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. doi:10.​1136/​bjophthalmol-2015-306733 PubMed
45.
Zurück zum Zitat Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN (2002) Primary orbital lymphoma. Hematol J 3:14–16CrossRefPubMed Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN (2002) Primary orbital lymphoma. Hematol J 3:14–16CrossRefPubMed
46.
Zurück zum Zitat Nagia L, Lemos J, Abusamra K, Cornblath WT, Eggenberger ER (2015) Prognosis of ocular myasthenia gravis: retrospective multicenter analysis. Ophthalmology 122:1517–1521CrossRefPubMed Nagia L, Lemos J, Abusamra K, Cornblath WT, Eggenberger ER (2015) Prognosis of ocular myasthenia gravis: retrospective multicenter analysis. Ophthalmology 122:1517–1521CrossRefPubMed
47.
Zurück zum Zitat MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J (1997) Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 41:423–431CrossRefPubMed MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J (1997) Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 41:423–431CrossRefPubMed
48.
Zurück zum Zitat Tsivgoulis G, Dervenoulas G, Kokotis P et al (2014) Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms. J Neurol Sci 346:328–330CrossRefPubMed Tsivgoulis G, Dervenoulas G, Kokotis P et al (2014) Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms. J Neurol Sci 346:328–330CrossRefPubMed
49.
Zurück zum Zitat Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE (2014) EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol 21:687–693CrossRefPubMed Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE (2014) EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol 21:687–693CrossRefPubMed
50.
Zurück zum Zitat Witting N, Mensah A, Køber L et al (2014) Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy. Acta Neurol Scand 130:125–130CrossRefPubMed Witting N, Mensah A, Køber L et al (2014) Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy. Acta Neurol Scand 130:125–130CrossRefPubMed
51.
Zurück zum Zitat Mancuso M, Orsucci D, Angelini C et al (2015) Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol 262:1301–1309CrossRefPubMed Mancuso M, Orsucci D, Angelini C et al (2015) Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol 262:1301–1309CrossRefPubMed
52.
53.
Zurück zum Zitat Kirsch E, Hammer B, Arx G (2009) Grave’s orbitopathy: current imaging procedures. Swiss Med Wkly 139(43–44):618–623PubMed Kirsch E, Hammer B, Arx G (2009) Grave’s orbitopathy: current imaging procedures. Swiss Med Wkly 139(43–44):618–623PubMed
54.
Zurück zum Zitat Moon WJ, Na DG, Ryoo JW et al (2003) Orbital lymphoma and subacute or chronic inflammatory pseudotumor: differentiation with two-phase helical computed tomography. J Comput Assist Tomogr 27:510–516CrossRefPubMed Moon WJ, Na DG, Ryoo JW et al (2003) Orbital lymphoma and subacute or chronic inflammatory pseudotumor: differentiation with two-phase helical computed tomography. J Comput Assist Tomogr 27:510–516CrossRefPubMed
55.
Zurück zum Zitat Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed
56.
Zurück zum Zitat Kau HC, Kao SC, Peng CH, Hsu WM, Tsai CC (2006) Methylprednisolone pulse therapy in patient with isolated superior oblique myositis. Eye (Lond) 20:1106–1109CrossRef Kau HC, Kao SC, Peng CH, Hsu WM, Tsai CC (2006) Methylprednisolone pulse therapy in patient with isolated superior oblique myositis. Eye (Lond) 20:1106–1109CrossRef
57.
Zurück zum Zitat El Nasser A, Mohammad A (2013) Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study. Ophthal Plast Reconstr Surg 29:286–289CrossRef El Nasser A, Mohammad A (2013) Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study. Ophthal Plast Reconstr Surg 29:286–289CrossRef
58.
Zurück zum Zitat Wong JK, Lee JW, Yuen CY (2014) Re: “Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study”. Ophthal Plast Reconstr Surg 30:532CrossRefPubMed Wong JK, Lee JW, Yuen CY (2014) Re: “Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study”. Ophthal Plast Reconstr Surg 30:532CrossRefPubMed
59.
Zurück zum Zitat Smith JR, Rosenbaum JT (2001) A role for methotrexate in the management of noninfectious orbital inflammatory disease. Br J Ophthalmol 85:1220–1224CrossRefPubMedPubMedCentral Smith JR, Rosenbaum JT (2001) A role for methotrexate in the management of noninfectious orbital inflammatory disease. Br J Ophthalmol 85:1220–1224CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Matthiesen C, Bogardus C Jr, Thompson JS et al (2011) The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys 79:1496–1502CrossRefPubMed Matthiesen C, Bogardus C Jr, Thompson JS et al (2011) The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys 79:1496–1502CrossRefPubMed
61.
Zurück zum Zitat Bau V, Sievert M, Roggenkämper P, Zierz S (2005) Cyclic vertical deviation after ocular myositis and treatment by recession of the inferior rectus muscle. Graefes Arch Clin Exp Ophthalmol 243:1062–1065CrossRefPubMed Bau V, Sievert M, Roggenkämper P, Zierz S (2005) Cyclic vertical deviation after ocular myositis and treatment by recession of the inferior rectus muscle. Graefes Arch Clin Exp Ophthalmol 243:1062–1065CrossRefPubMed
62.
Zurück zum Zitat Bessant DA, Lee JP (1995) Management of strabismus due to orbital myositis. Eye (Lond) 9:558–563CrossRef Bessant DA, Lee JP (1995) Management of strabismus due to orbital myositis. Eye (Lond) 9:558–563CrossRef
63.
Zurück zum Zitat Bunting HJ, Dawson EL, Lee JP, Adams GG (2013) Role of inferior rectus botulinum toxin injection in vertical strabismus resulting from orbital pathology. Strabismus 21:165–168CrossRefPubMed Bunting HJ, Dawson EL, Lee JP, Adams GG (2013) Role of inferior rectus botulinum toxin injection in vertical strabismus resulting from orbital pathology. Strabismus 21:165–168CrossRefPubMed
Metadaten
Titel
“Orbiting around” the orbital myositis: clinical features, differential diagnosis and therapy
verfasst von
F. Montagnese
S. Wenninger
B. Schoser
Publikationsdatum
17.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 4/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7926-x

Weitere Artikel der Ausgabe 4/2016

Journal of Neurology 4/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.